|
515 Companies |
|
302 Products |
|
302 Products |
|
167 Mechanisms of Action |
|
1404 Trials |
|
125634 News |
|
| «12...15521553155415551556155715581559156015611562...15771578» |
- | voriconazole / Generic mfg.
Trial completion: Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed
- Trial completion, Metastases: Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Daiichi Sankyo Inc.
No longer recruiting --> Completed Suspended --> Completed
- | Trial completion: Alanosine in Treating Patients With Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed Active, not recruiting --> Completed
- | imatinib / Generic mfg.
Trial completion: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor (clinicaltrials.gov) - Feb 22, 2014
P2, N=40, Completed, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Zarnestra (tipifarnib) / Kura Oncology
Trial completion: Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (clinicaltrials.gov) - Feb 22, 2014
P2, N=54, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | perifosine (D21266) / AEterna Zentaris
Trial completion, Metastases: Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed Suspended --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed No longer recruiting --> Completed
- | Trial completion: Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=637, Completed, Sponsor: Children's Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | oxaliplatin / Generic mfg.
Trial completion: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor (clinicaltrials.gov) - Feb 22, 2014
P2, N=43, Completed, Sponsor: Pediatric Brain Tumor Consortium
Active, not recruiting --> Completed No longer recruiting --> Completed
- | arsenic trioxide / Generic mfg.
Trial completion: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion: SWOG S0218: Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung (clinicaltrials.gov) - Feb 22, 2014
P2, N=55, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Marqibo (vincristine liposomal) / Servier, Aurobindo
Trial completion: Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies (clinicaltrials.gov) - Feb 22, 2014
P2, N=29, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Terminated --> Completed
- | ABT-751 / AbbVie, Eisai
Trial completion: ABT-751 in Treating Young Patients With Refractory Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=90, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Terminated --> Completed Active, not recruiting --> Completed
- | imatinib / Generic mfg.
Trial completion, Metastases: Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (clinicaltrials.gov) - Feb 22, 2014
P1, N=75, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Suspended --> Completed
- | Ixempra (ixabepilone) - Otsuka, R / Pharm, Allarity Therap, patupilone (EPO 906) / Novartis
Trial completion: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Suspended --> Completed Recruiting --> Completed
- | temozolomide / Generic mfg.
Trial completion, Surgery: Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma (clinicaltrials.gov) - Feb 22, 2014
P2, N=170, Completed, Sponsor: Children's Oncology Group
Recruiting --> Completed Active, not recruiting --> Completed
- | bortezomib / Generic mfg.
Trial completion, Metastases: Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma (clinicaltrials.gov) - Feb 22, 2014
P2, N=106, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | imatinib / Generic mfg.
Trial completion, Metastases: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (clinicaltrials.gov) - Feb 22, 2014
P1, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Tirazone (tirapazamine) / Teclison, SRI International
Trial completion, Combination therapy: Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=150, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | gefitinib / Generic mfg.
Trial completion: Gefitinib in Treating Patients With Malignant Mesothelioma (clinicaltrials.gov) - Feb 22, 2014
P2, N=40, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion, Metastases: Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=80, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- | semaxanib (SU5416) / Pfizer
Trial completion, Surgery: Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
No longer recruiting --> Completed Not yet recruiting --> Completed
- sorafenib / Generic mfg.
Enrollment change: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer (clinicaltrials.gov) - Feb 20, 2014
P2, N=20, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed N=80 --> 20
- sorafenib / Generic mfg.
Trial completion: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer (clinicaltrials.gov) - Feb 20, 2014
P2, N=20, Completed, Sponsor: National Cancer Institute (NCI)
N=80 --> 20 Recruiting --> Completed
- | imatinib / Generic mfg.
Trial completion, Stroma, Metastases: Prospective Multicentric Randomized Study of Glivec (clinicaltrials.gov) - Feb 20, 2014
P3, N=564, Completed, Sponsor: Centre Leon Berard
Recruiting --> Completed Active, not recruiting --> Completed
- | melphalan / Generic mfg., dactinomycin / Generic mfg.
Trial completion, Surgery: Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery (clinicaltrials.gov) - Feb 19, 2014
P2, N=35, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | ifosfamide / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases: Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus (clinicaltrials.gov) - Feb 19, 2014
P3, N=166, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | DaunoXome (liposomal daunorubicin) / SOBI, Galen
Trial completion: Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | rebimastat (BMS-275291) / BMS
Trial completion: BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=59, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed No longer recruiting --> Completed
- | semaxanib (SU5416) / Pfizer
Trial completion: Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
No longer recruiting --> Completed Not yet recruiting --> Completed
- | Yondelis (trabectedin) / Otsuka, PharmaMar, Valeo Pharma, J&J
Trial completion, Metastases: Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Torisel (temsirolimus) / Pfizer
Trial completion: CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme (clinicaltrials.gov) - Feb 19, 2014
P2, N=33, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | gefitinib / Generic mfg.
Trial completion: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (clinicaltrials.gov) - Feb 19, 2014
P2, N=92, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: COG-AEWS0031: Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor (clinicaltrials.gov) - Feb 19, 2014
P3, N=587, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | busulfan / Generic mfg.
Trial completion: Busulfan in Treating Children and Adolescents With Refractory CNS Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=28, Completed, Sponsor: Pediatric Brain Tumor Consortium
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Metastases: Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=200, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- | thalidomide / Generic mfg.
Trial completion: Thalidomide in Treating Patients With Gynecologic Sarcomas (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: New York University Cancer Institute
No longer recruiting --> Completed No longer recruiting --> Completed
- | alvocidib (DSP-2033) / Sumitomo Pharma
Trial completion, Metastases: Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=18, Completed, Sponsor: NCIC Clinical Trials Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | temozolomide / Generic mfg.
Trial completion: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=30, Completed, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Completed
- | semaxanib (SU5416) / Pfizer
Trial completion, Metastases: SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Not yet recruiting --> Completed
- | pegylated liposomal doxorubicin / Generic mfg.
Trial completion, Metastases: Chemotherapy in Treating Patients With Sarcoma of the Uterus (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Not yet recruiting --> Completed No longer recruiting --> Completed
- | Yondelis (trabectedin) / Otsuka, PharmaMar, Valeo Pharma, J&J
Trial completion, Metastases: Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | temozolomide / Generic mfg.
Trial completion, Stroma, Metastases: S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=25, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | carboplatin / Generic mfg., cisplatin / Generic mfg., floxuridine / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=45, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tanespimycin (BMS-722782) / BMS
Trial completion, Metastases: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed